Geneos Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-53
| Closed | -$8.49K | – | 3223 |
|
2025
Q1 | $8.49K | Buy |
53
+37
| +231% | +$5.93K | ﹤0.01% | 2614 |
|
2024
Q4 | $1.95K | Buy |
+16
| New | +$1.95K | ﹤0.01% | 2603 |
|
2024
Q2 | – | Sell |
-4
| Closed | -$518 | – | 2170 |
|
2024
Q1 | $518 | Buy |
+4
| New | +$518 | ﹤0.01% | 2119 |
|
2022
Q3 | – | Sell |
-118
| Closed | -$8K | – | 2522 |
|
2022
Q2 | $8K | Hold |
118
| – | – | ﹤0.01% | 2049 |
|
2022
Q1 | $9K | Hold |
118
| – | – | ﹤0.01% | 2134 |
|
2021
Q4 | $10K | Hold |
118
| – | – | ﹤0.01% | 2191 |
|
2021
Q3 | $11K | Hold |
118
| – | – | ﹤0.01% | 2194 |
|
2021
Q2 | $8K | Hold |
118
| – | – | ﹤0.01% | 2305 |
|
2021
Q1 | $8K | Hold |
118
| – | – | ﹤0.01% | 2499 |
|
2020
Q4 | $8K | Hold |
118
| – | – | ﹤0.01% | 2327 |
|
2020
Q3 | $16K | Buy |
118
+50
| +74% | +$6.78K | ﹤0.01% | 1767 |
|
2020
Q2 | $11K | Sell |
68
-50
| -42% | -$8.09K | ﹤0.01% | 1892 |
|
2020
Q1 | $11K | Hold |
118
| – | – | ﹤0.01% | 1787 |
|
2019
Q4 | $15K | Hold |
118
| – | – | ﹤0.01% | 1815 |
|
2019
Q3 | $8K | Hold |
118
| – | – | ﹤0.01% | 1978 |
|
2019
Q2 | $17K | Hold |
118
| – | – | ﹤0.01% | 1720 |
|
2019
Q1 | $14K | Sell |
118
-100
| -46% | -$11.9K | ﹤0.01% | 1724 |
|
2018
Q4 | $23K | Hold |
218
| – | – | ﹤0.01% | 1446 |
|
2018
Q3 | $35K | Sell |
218
-180
| -45% | -$28.9K | ﹤0.01% | 1339 |
|
2018
Q2 | $52K | Sell |
398
-120
| -23% | -$15.7K | ﹤0.01% | 1025 |
|
2018
Q1 | $38K | Buy |
518
+400
| +339% | +$29.3K | ﹤0.01% | 1129 |
|
2017
Q4 | $6K | Hold |
118
| – | – | ﹤0.01% | 1782 |
|
2017
Q3 | $5K | Hold |
118
| – | – | ﹤0.01% | 1770 |
|
2017
Q2 | $3K | Sell |
118
-333
| -74% | -$8.47K | ﹤0.01% | 1868 |
|
2017
Q1 | $13K | Buy |
451
+250
| +124% | +$7.21K | ﹤0.01% | 1400 |
|
2016
Q4 | $5K | Sell |
201
-50
| -20% | -$1.24K | ﹤0.01% | 1645 |
|
2016
Q3 | $15K | Sell |
251
-50
| -17% | -$2.99K | ﹤0.01% | 1242 |
|
2016
Q2 | $6K | Buy |
301
+100
| +50% | +$1.99K | ﹤0.01% | 1479 |
|
2016
Q1 | $4K | Buy |
+201
| New | +$4K | ﹤0.01% | 1564 |
|